Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1089278-81-8

Post Buying Request

1089278-81-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1089278-81-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1089278-81-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,8,9,2,7 and 8 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1089278-81:
(9*1)+(8*0)+(7*8)+(6*9)+(5*2)+(4*7)+(3*8)+(2*8)+(1*1)=198
198 % 10 = 8
So 1089278-81-8 is a valid CAS Registry Number.

1089278-81-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(1-Methyl-1H-pyrazol-4-yl)aniline

1.2 Other means of identification

Product number -
Other names N-methyl-indol-3-ylpropanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1089278-81-8 SDS

1089278-81-8Relevant articles and documents

2-pyridine substituted urea structural small molecule compounds as well as synthesis and application thereof

-

Paragraph 0197; 0286-0288, (2020/03/03)

The invention relates to 2-pyridine substituted urea structural small molecule compounds as well as synthesis and application thereof. Specifically, the invention discloses the compounds represented by a formula (I) shown in the specification, enantiomers, diastereomers, racemates or a mixture of the compounds, or a pharmaceutically acceptable salt, hydrate and solvate of the compounds, a preparation method of the above materials, and applications of the above materials in preparation of an ASK1 small molecule inhibitor, or medicines for preventing and/or treating diseases related to ASK1, especially liver diseases, lung diseases, cardiovascular diseases, kidney diseases and metabolic diseases.

THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE

-

Page/Page column 223, (2012/02/02)

Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1 comprising administering to a subject in need thereof a compound described here.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1089278-81-8